Publishes reports of novel results in any area of immunology. Subjects encompass all immune response systems, including molecular immunology, infectious disease, genetics, cell biology, biochemistry and virology. Immunity is a medical journal from Cell Press covering immunology and infectious diseases. Coverage Includes: immune cell development and senescence, signal transduction, gene regulation, innate and adaptive immunity, cytokines and inflammatory responses, autoimmunity and tolerance, Infectious disease, tumor immunology, vaccine biology, transplantation biology, allergy and asthma The outlet offers RSS (Really Simple Syndication).

Edited to serve as an information resource rather than a conventional medium for original research reports. Focuses on cellular immunology; immunogenetics; molecular and structural immunology; immunoregulation and autoimmunity; immunopathology; tumor immunology; host defense and microbial immunity; immunotoxicology; immunobiology; immunophysiology; immunopharmacology; viral immunology; immunohematology; mucosal immunology; complement; transplantation immunology; history of immunology; clinical immunology; neuroimmunology; and immunoendocrinology.

Impact Factor: 3.701 Ranking: ISI Journal Citation Reports © Ranking: 55/151 (Immunology) Circulation: The publisher does not want disclose the circulation figure for the journal. Aims of the journal: Recognised as one of the leading journals in its field it is also one of the longest established immunology journals, with a wide trans-continental representation in authors, editors and reviewers. Readership: Immunology aims to be essential reading for workers in all areas of immunological research. The readership includes research workers, university and college lecturers and clinical researchers (approx 80%); and laboratory technicians (20%). Content: The journal publishes papers describing original work in all areas of immunology including: Cellularand molecular immunology Immunochemistry Immunogenetics Imaging Mathematical modelling Allergy Transplantation immunology Cancer immunology Clinical immunology Original articles describing mechanistic insights to the immune system are particularly welcome. The journal also publishes commissioned review articles on subjects of topical interest to immunologists. The editors are also prepared to consider unsolicited review suggestions in the form of submitted Abstracts. Manuscript submission: Instructions for authors can be viewed here Online submission at http://mc.manuscriptcentral.com/imm

Resource for groundbreaking clinical and basic research in the disciplines of immunopharmacology and immunotoxicology, furnishing original scientific papers, brief communications and reviews on the alterations of the immune system and other relevant topics such as the disease-mediating capacity of immunomodulating agents. Features experimental and clinical results on cytokines and chemokines, vaccines, nutrition and neuroimmunopharmacology. Provides coverage on immunomodifying agents to treat diseases such as cancer, immunodeficiency, chronic infection, allergy, and inflammatory and autoimmune disorders, and the adverse or positive effects of xenobiotics on the immune system, including chemicals, metals, food additives and airborne pollutants.

The journal aims to deliver essential information in concise, at-a-glance article formats. Key advances in the field are reported and analyzed by international experts, providing an authoritative but accessible forum for this vitally important area of research.Content:Articles published in Immunotherapy include key areas such as: Cancer immunotherapy, including cancer vaccines and passive immunotherapeutic approaches Combined chemo/radioimmunotherapy in cancer treatment Restorative immunotherapy for AIDS and other immunocompromised patients Suppressive immunotherapy for autoimmunity diseases and transplantation Basic science of immunotherapeutic approaches Drug–immune system interactions Drug delivery systems, drug combinations and drug-drug interactions Summaries evaluating newly approved immunotherapeutic agents Newly identified immune targets of drugs Results of recent findings and clinical trials relevant to the field of immunotherapy Postmarketing research, including adverce events, drug safety, pharmacoeconomics and cost–benefit issuesEditorial contacts:A full list of editorial contacts can be found hereManuscript Submission:Author guidelines can be viewed at here.Online manuscript submission can be found here.Ad Rates:Further information on ad rates can be found here.

Written for scientists and research institutions involved in immunotherapy. Editorial mission is to provide insight into the immunologic bases of diseases and immune system dysfunctions, while emphasizing biological agents and biotechnology. Topics include vaccines, gene therapy, immunoconjugates, cancer biotechnology, monoclonal antibodies, cytokines and immunomodulators. NewsRX™ is a digital news, publishing technology and IT company and uses an automated article writing and periodical production software platform (Artificial Intelligence Journalist – AIJ) producing 35,000 unique articles weekly and 195 autocreated digital newsweeklies. Artificial Intelligence Journalist™ (“AIJ”) and Artificial Intelligence Editor™ (“AIE”), is a proprietary software technology which automates every aspect of publishing, from writing and editing to distribution and analytics.

Michelle Obama and her big brother Craig Robinson bring their unique experiences and candid perspectives to a range of listeners' personal dilemmas, from the everyday to the existential. Each week, they're joined by special guests to tackle audience questions with practical advice, relatable anecdotes, and plenty of laughs. From dating and relationships to parenting and financial planning, IMO sees the iconic First Lady at her most relaxed and honest. This podcast will leave you laughing, reflecting, and feeling more prepared to tackle life's challenges. Join the fun and submit your questions at <a href="http://imopod.com" rel="noopener noreferrer" target="_blank">imopod.com</a>!

iMoneyNet provides yields, assets, average maturities and portfolio composition statistics for more than 1,800 money-market mutual funds, as well as category averages and insightful commentary.

Written for iPhone, iPod and iPad users. Features news, information, reviews, tips and tricks. The fundamentals of working with bloggers are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to read their material to learn their interests; and only contact them if/when they want to be contacted. You will also find that if a blogger is a journalist for another outlet(s), Cision tracks their contact preferences there as well. The outlet offers RSS (Really Simple Syndication). PR opportunities are available for reviews, news items, brand name or product placement, competitions and possibly interviews. The team can be reached via the email above. To specifically submit an iOS app for review, email iosapps@imore.com.

iMore show is a tech podcast. A podcast is a downloadable video or audio broadcast show. Most podcasts are available by subscription through an RSS reader or other aggregator. The fundamentals of working with podcasters are the same as with traditional journalists at traditional media outlets: respect their schedules; take time to watch or listen to their material to learn their interests, format of content; and only contact them if relevant.